Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Lo-Coco

Showing results (171-180 of 204) with videos related to

Pageof 21
Sort By:
Blood|December 16, 2014
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutationsMargherita Bodini, Chiara Ronchini, Luciano Giacò, et al.
Blood|February 27, 2019
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetMiguel A Sanz, Pierre Fenaux, Martin S Tallman, et al.
Blood|June 16, 2010
Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemiaFrancesco Buccisano, Luca Maurillo, Alessandra Spagnoli, et al.
Seminars in Hematology|December 4, 2018
Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcomeMaria Ilaria Del Principe, Francesco Buccisano, Stefano Soddu, et al.
Annals of Hematology|June 10, 2017
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapyOussama Abla, Raul C Ribeiro, Anna Maria Testi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 23, 2016
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical ApplicationsMaria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, et al.
The New England Journal of Medicine|January 22, 2005
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotypeBrunangelo Falini, Cristina Mecucci, Enrico Tiacci, et al.
Blood|April 8, 2006
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Francesco Buccisano, et al.
Cell Research|April 27, 2019
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapyVera Mugoni, Riccardo Panella, Giulia Cheloni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaBruce D Cheson, John M Bennett, Kenneth J Kopecky, et al.
Pageof 21

Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Blood|December 16, 2014
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutationsMargherita Bodini, Chiara Ronchini, Luciano Giacò, et al.
Blood|February 27, 2019
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetMiguel A Sanz, Pierre Fenaux, Martin S Tallman, et al.
Blood|June 16, 2010
Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemiaFrancesco Buccisano, Luca Maurillo, Alessandra Spagnoli, et al.
Seminars in Hematology|December 4, 2018
Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcomeMaria Ilaria Del Principe, Francesco Buccisano, Stefano Soddu, et al.
Annals of Hematology|June 10, 2017
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapyOussama Abla, Raul C Ribeiro, Anna Maria Testi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 23, 2016
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical ApplicationsMaria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, et al.
The New England Journal of Medicine|January 22, 2005
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotypeBrunangelo Falini, Cristina Mecucci, Enrico Tiacci, et al.
Blood|April 8, 2006
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Francesco Buccisano, et al.
Cell Research|April 27, 2019
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapyVera Mugoni, Riccardo Panella, Giulia Cheloni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaBruce D Cheson, John M Bennett, Kenneth J Kopecky, et al.
Pageof 21